Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Indivior PLC Board/Management Information 2022

Nov 15, 2022

4923_mang_2022-11-15_296efe05-9a13-4714-8756-82854ea69009.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 4560G

Indivior PLC

15 November 2022

Indivior PLC (the 'Company')

Indivior PLC confirms that Peter Bains, Independent Non-Executive Director, was appointed as an Independent Director of Biocon Limited, a biopharmaceutical company listed on the National Stock Exchange of India, with effect from November 14, 2022.

This announcement is made in accordance with Listing Rule 9.6.14.

Kathryn Hudson

Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RDNBKPBPCBDKCDD